New Alzheimer's treatments seem painfully slow to emerge for those currently living with the disease or watching a loved one suffer. Medications presently available temporarily improve symptoms of memory loss, thinking, and reasoning, but they don’t stop the decline and death of brain cells.   Discovering how to control that decline is akin to the holy grail in Alzheimer’s research and would offer millions of people hope. Although there is no guarantee that a cure is imminent, there is a reason for optimism. FirstLantic explores five different Alzheimer's treatment paths in the research phase that are showing promise.   Saracatinib.  A drug initially developed as a possible cancer treatment is now being tested for Alzheimer's treatment. In studies, Saracatinib turned off a protein that allowed synapses [...]